These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25715092)

  • 1. Primary aldosteronism and its various clinical scenarios.
    Martell-Claros N; Abad-Cardiel M; Alvarez-Alvarez B; García-Donaire JA; Pérez CF
    J Hypertens; 2015 Jun; 33(6):1226-32. PubMed ID: 25715092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.
    Loh KC; Koay ES; Khaw MC; Emmanuel SC; Young WF
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2854-9. PubMed ID: 10946893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypokalemic rhabdomyolysis: a rare manifestation of primary aldosteronism.
    Zavatto A; Concistrè A; Marinelli C; Zingaretti V; Umbro I; Fiacco F; Tinti F; Petramala L; Mitterhofer AP; Letizia C
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(20):3910-6. PubMed ID: 26531278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism.
    Murata M; Kitamura T; Tamada D; Mukai K; Kurebayashi S; Yamamoto T; Hashimoto K; Hayashi RD; Kouhara H; Takeiri S; Kajimoto Y; Nakao M; Hamasaki T; Otsuki M; Shimomura I
    J Hypertens; 2017 May; 35(5):1079-1085. PubMed ID: 28129245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of primary aldosteronism by clinical features and daily laboratory tests: combination of urine pH, sex, and serum K.
    Yamashita T; Shimizu S; Koyama M; Ohno K; Mita T; Tobisawa T; Takada A; Togashi N; Ohnuma Y; Hasegawa T; Tsuchida A; Endo T; Ando T; Yoshida H; Fukuma S; Fukuhara S; Moniwa N; Miura T
    J Hypertens; 2018 Feb; 36(2):326-334. PubMed ID: 28832364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged Hypokalemia and Delayed Diagnosis of Primary Aldosteronism: Clinical Course and Risk Factors.
    Gupta G; Teo AED; Swee DS; Loh LM; Chuah M; Loh WJ; Saffari SE; Koh XH; Kek PC; Puar TH
    J Clin Endocrinol Metab; 2024 Jul; 109(8):e1574-e1581. PubMed ID: 38134306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unawareness of Primary Aldosteronism as a Common Cause of Hypokalemia - Insights from the IPAHK+ Trial (Incidence of Primary Aldosteronism in Patients with Hypokalemia).
    Gruber S; Stasi E; Pion AB; Steiner R; Erlic Z; Bornstein SR; Sudano I; Reincke M; Beuschlein F
    Horm Metab Res; 2024 Apr; 56(4):300-307. PubMed ID: 37924818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary aldosteronism in the primary care setting.
    Buffolo F; Monticone S; Tetti M; Mulatero P
    Curr Opin Endocrinol Diabetes Obes; 2018 Jun; 25(3):155-159. PubMed ID: 29629943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.
    Ohno Y; Sone M; Inagaki N; Yamasaki T; Ogawa O; Takeda Y; Kurihara I; Itoh H; Umakoshi H; Tsuiki M; Ichijo T; Katabami T; Tanaka Y; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Yamamoto K; Ogo A; Okamura S; Miyauchi S; Fukuoka T; Izawa S; Yoneda T; Hashimoto S; Yanase T; Suzuki T; Kawamura T; Tabara Y; Matsuda F; Naruse M; ;
    Hypertension; 2018 Mar; 71(3):530-537. PubMed ID: 29358460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on Primary Aldosteronism: Time to Screen All Hypertensives.
    Memon SS; Bandgar T
    J Assoc Physicians India; 2024 Jan; 72(1):11-12. PubMed ID: 38736067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
    Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A
    Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening Rates for Primary Aldosteronism Among Individuals With Hypertension Plus Hypokalemia: A Population-Based Retrospective Cohort Study.
    Hundemer GL; Imsirovic H; Vaidya A; Yozamp N; Goupil R; Madore F; Agharazii M; Knoll G; Sood MM
    Hypertension; 2022 Jan; 79(1):178-186. PubMed ID: 34657442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
    Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population.
    Chen Y; Chen X; Chen Q; Yu C
    Front Endocrinol (Lausanne); 2021; 12():565714. PubMed ID: 33967948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone?
    Stavropoulos K; Imprialos KP; Katsiki N; Petidis K; Kamparoudis A; Petras P; Georgopoulou V; Finitsis S; Papadopoulos C; Athyros VG; Doumas M; Karagiannis A
    J Clin Hypertens (Greenwich); 2018 May; 20(5):942-948. PubMed ID: 29722113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry.
    Born-Frontsberg E; Reincke M; Rump LC; Hahner S; Diederich S; Lorenz R; Allolio B; Seufert J; Schirpenbach C; Beuschlein F; Bidlingmaier M; Endres S; Quinkler M;
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1125-30. PubMed ID: 19190103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypokalemia and the Prevalence of Primary Aldosteronism.
    Gruber S; Beuschlein F
    Horm Metab Res; 2020 Jun; 52(6):347-356. PubMed ID: 32252108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites.
    Schirpenbach C; Seiler L; Maser-Gluth C; Rüdiger F; Nickel C; Beuschlein F; Reincke M
    Eur J Endocrinol; 2006 Jun; 154(6):865-73. PubMed ID: 16728547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.